美国投机情报区-Dubai神話破滅

cloudwin

ABK竟然冲到酱厉害 。。。两天前刚考虑要不要进而已

m.i.k.e

ABK 1.80 +0.57  46.34%  
CIT 1.56 +0.29  22.83%

最近有人不出声,原来是静静地在赚.......
昨晚有没有大声欢呼而被邻居投诉啊?.....

原帖由 jochen 于 27-8-2009 09:09 PM 发表


我只不过 cover 之前的 loses....
你点的每个都飞了。。。。。

点石成金。。。。
golden finger....

你点的每个都飞了。。。。。。 我不信这一套...什么点石成金.....我只不过是幸运买到飙升的股而已.......在股市里作战,运气好是非常重要的....

你如果运气不好....什么理论,看图表,基本面,技术面...全部都是假的.

葉芬

原帖由 m.i.k.e 于 28-8-2009 08:32 AM 发表
ABK 1.80 +0.57  46.34%  
CIT 1.56 +0.29  22.83%

最近有人不出声,原来是静静地在赚.......
昨晚有没有大声欢呼而被邻居投诉啊?.....

你点的每个都飞了。。。。。。 我不信这一套...什么点石 ...

你又來找砸啦。。。

CVM 有人買進嗎？ 昨晚 Last few minutes 。。。 漲到0.71 ， AfterHour  0,74
昨晚在前半夜有跌至0.58...  
根據我們國際區的金手指麥麥，他/她的分析，這股還有上漲的空間。

m.i.k.e

原帖由 葉芬 于 28-8-2009 09:21 AM 发表



你又來找砸啦。。。

CVM 有人買進嗎？ 昨晚 Last few minutes 。。。 漲到0.71 ， AfterHour  0,74
昨晚在前半夜有跌至0.58...  
根據我們國際區的金手指麥麥，他/她的分析，這股還有上漲的空間。 ...

大家要是因为 CVM 而亏钱的话,记得要找叶芬.....
我会给你们他的联络电话.....请大家好好修理他.

葉芬

原帖由 m.i.k.e 于 28-8-2009 09:30 AM 发表
大家要是因为 CVM 而亏钱的话,记得要找叶芬.....
我会给你们他的联络电话.....请大家好好修理他.

買賣自負！  

joanne27

看AIG 每天都再起，心好痛本想买进１００ unit 但husband 不鼓厉，我看不管这样多了。今晚就进１００ unit 了，大家祝我好迎

葉芬

原帖由 joanne27 于 28-8-2009 09:51 AM 发表
看AIG 每天都再起，心好痛本想买进１００ unit 但husband 不鼓厉，我看不管这样多了。今晚就进１００ unit 了，大家祝我好迎

股票大起時進場很容易中套。
要是能等她退熱些再進場更好。

joanne27

谢谢你忠告。不然芬姐有好介绍吗？

m.i.k.e

原帖由 葉芬 于 28-8-2009 10:02 AM 发表



股票大起時進場很容易中套。
要是能等她退熱些再進場更好。

请问股市几时才会退热?
谢谢 !

laguna7888

各位可以帮忙看看这些股：AFN, AI, BBI, CHB, AHR, GBE.

laguna7888

AFN, AI, BBI, CHB, AHR, GBE.

仙家大炮王

標普調降American Capital評級
08/24/2009 11:11AM

標普評級服務公司今天調降了American Capital Ltd(NASDAQ:ACAS,新聞,圖表)的債務評級，理由是對該公司的債務和盈餘表現的擔憂。標普將該公司的長期對手信貸評級由BB-調降至了B-，並將其前景定為了負面評級。今日盤中該公司股價下跌5.8%至2.76美元。

napster

Andy Lau 朱丽倩守了24年。
我也守了CIT, ABK 14天。

FRE, FNM, C, AIG 可以收山了。
这次轮到CIT, ABK 被炒。
CORS应该可以博一博

仙家大炮王

NASDAQORS (Corus Bankshares)

內部交易


公司最近的內部交易記錄

日期 名字/職位 類型 股數 價格
2009/8/20 GLICKMAN EDWARD W
賣出  491527  0.3543  
2009/8/19 GLICKMAN EDWARD W
賣出  440723  0.375  
2009/6/16 GLICKMAN ROBERT J
賣出  334691  0.3  
2009/6/15 GLICKMAN ROBERT J
賣出  390498  0.32  
2009/6/12 GLICKMAN ROBERT J
賣出  970123  0.35  
2009/6/11 GLICKMAN ROBERT J
賣出  752714  0.36  
2009/6/10 GLICKMAN ROBERT J
賣出  391879  0.37  
2009/6/9 GLICKMAN ROBERT J
賣出  14126  0.39  
2009/6/8 GLICKMAN ROBERT J
賣出  16653  0.41  
2009/6/5 GLICKMAN ROBERT J
賣出  485178  0.43  
2009/6/4 GLICKMAN ROBERT J
賣出  800248  0.43  
2009/6/3 GLICKMAN ROBERT J
賣出  111074  0.41  
2009/6/2 GLICKMAN EDWARD W
賣出  94664  0.39  
2009/6/2 GLICKMAN ROBERT J
賣出  301497  0.4196  
2009/6/1 GLICKMAN ROBERT J
賣出  833978  0.44  
2009/5/27 GLICKMAN ROBERT J
賣出  152656  0.4227  
2009/5/26 GLICKMAN ROBERT J
賣出  163248  0.4223  
2009/5/22 GLICKMAN ROBERT J
賣出  763751  0.4681  
2008/11/13 GLICKMAN EDWARD W
賣出  30000  1.86

wobushi

个人看法，
等fre, fnm 和aig 跌个20%， 再买也不迟。。。

WASHINGTON (AP) -- Investors are still trading common shares of Fannie Mae, Freddie Mac and American International Group Inc. by the billions, even though analysts say their prices are almost certain to go to zero.

All three are majority-owned by the government and are losing huge sums of money. The Securities and Exchange Commission and other regulators lack authority to end trading of stocks in such "zombie" companies that technically are alive -- until the government takes them off life support.

joanne27

naster 你的ABK是什么价位买进呢？现在已１。８０还有上的空间吗？

SUNNY仔

想问很久了..AFTER HOURS的价钱是可以用来做隔天开市时的指标价钱吗?

葉芬

CVM - 轉帖

New Facility brings in $150,000 per every 8 HOUR contract fill

New details have begun to emerge about Cel-Sci Corporation's (CVM)
new, state-of-the-art "Cold-Fill" manufacturing facility which will
not only be used to manufacture Multikine® the world's first
immunotherapeutic agent (which is being developed as a first-line
standard of care treatment for cancer) for both the Phase III trials
and commercial sales, but Cel-Sci plans to offer the use of the
facility as a service to pharmaceutical companies and others,
particularly those that need to "fill and finish" their drugs in a
cold environment (4 degrees Celsius, or approximately 39 degrees
Fahrenheit).

This is a key process of filling injectable drugs in a sterile manner
and is an important part of the manufacturing process for many
medicines.

This lab, which many now consider a cornerstone to the future
financial success of the company is located near Baltimore, MD.
According to newly released documents filed with the SEC, it was
designed over several years, and was built out to Cel-Sci's
specifications during the past 18 months.

One insider calls it "absolutely state-of-the art" and "extremely
impressive down to the smallest detail."

An interview between Cel-Sci's CEO, Geert Kersten, has been scheduled
and more details will follow at BioMedReports, but I can tell you that
Cel-Sci believes it will be able to charge approximately $150,000 for
an eight hour fill and finish "run" at this extremely unique facility
whose aseptic filling suites are maintained at FDA and EU ISO
classifications of 5/6.

Cel-Sci also has the capability to formulate, inspect, label and
package biologic products at cold temperatures. Furthermore, the
company discloses that they do not know of any other facility in the
United States which is able to provide cold 4 degrees Celsius finish
and fill services on a contract basis.

What this will mean for the financial security and future of the
company is significant, particularly given the fact that the fastest
area of growth in the biopharmaceutical and pharmaceutical markets is
biologics, and most recently stem cell products.

These compounds and therapies are derived from or mimic human cells or
proteins and other molecules (e.g., hormones, etc.). Nearly all of the
major drugs developed for unmet medical needs (e.g., Avastin(R),
Erbitux(R), Rituxan(R), Herceptin(R), Copaxon(R), etc.) are biologics.
Biologics are usually very sensitive to such things as heat and
humidity and are known to quickly lose their biological activity if
exposed to room or elevated temperatures (which may also affect the
shelf-life of a biologic - with the result being that the product
cannot be stored for as long as desired).

These products do not generally lose activity when kept at 4 degrees
Celsius.

Shares of Cel-Sci continue to tick upward as signs point to a
resurrection of sorts for this biotech play that many had on the ropes
and ready for a knock-out punch

cct2049

CEL-SCI出售普通股与权证，集资440万美元   2009年08月21日

      SCI Corp (CVM)宣布与数位法人机构投资人签署协议，将出售970万单位，每单位包括一股公司普通股与可认购1股的0.5张权证，集资440万美元，投资人同意以每单位0.45美元买进这些单位。

仙家大炮王

股票名稱／代號：CEL SCI CP (CVM) 資料日期：08/28/2009
時間	成交價	買進	賣出	漲跌	成交量	昨收	開盤
04:00am	0.70	0.67	0.76	+0.00	0	0.70	0.00
最高	最低	一年內最高及最低			本益比	每股營利	總市值
0.00	0.00	0.14 - 0.80			-7.78	-0.09	104.684M